Skip to content
Descubridor Institucional UMAR
Inicio
Búsqueda avanzada
Explorar
Inicio
Búsqueda avanzada
Explorar
Login
Language
English
Deutsch
Español
Français
Italiano
All Fields
Title
Author
Subject
Call Number
ISBN/ISSN
Tag
Find
Advanced
Utilizing Altmetrics to Track Advancements in Noninvasive Tests for MASLD
Utilizing Altmetrics to Track Advancements in Noninvasive Tests for MASLD
Fuente:
Wiley Open Access
Saved in:
Bibliographic Details
Main Authors:
Masato Yoneda
,
Yoshio Sumida
,
Yoshihiro Kamada
,
Hirokazu Takahashi
,
Hideki Fujii
,
Shinichi Takeda
,
Azadeh Hosseini‐Tabatabaei
,
Atsushi Nakajima
Format:
Artículo Open Access
Published:
Wiley
2025
Subjects:
Hepatology Research
Online Access:
Acceder al recurso
Tags:
Add Tag
No Tags, Be the first to tag this record!
Cite this
Text this
Email this
Print
Export Record
Export to RefWorks
Export to EndNoteWeb
Export to EndNote
Save to List
Permanent link
Holdings
Description
Comments
Similar Items
Staff View
Internet
https://onlinelibrary.wiley.com/doi/10.1111/hepr.14229
Similar Items
Optimizing VCTE and ELF Thresholds for Treatment‐Eligible F2–F3 Fibrosis in Japanese Patients With MASLD
by: Yuya Seko, et al.
Published: (2026)
Response to the Letter “Steatotic Liver Disease and the ‘Point of No Return’ in the Development of Metabolic Disorders”
by: Yoshihiro Kamada
Published: (2026)
Response to the Letter “Steatotic Liver Disease: A Key Related Risk Factor in the Emergence of Metabolic Syndrome‐Related Disorders”
by: Yoshihiro Kamada
Published: (2026)
Validation study of age‐independent fibrosis score (Fibrosis‐3 index) in patients with metabolic dysfunction‐associated steatotic liver disease
by: Kazuhiro Nouso, et al.
Published: (2024)
Evidence‐Based Clinical Practice Guidelines for Metabolic Dysfunction–Associated Steatotic Liver Disease (MASLD) 2026
by: Norio Akuta, et al.
Published: (2026)